Marc Lipman

17.5k total citations · 2 hit papers
292 papers, 9.2k citations indexed

About

Marc Lipman is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Marc Lipman has authored 292 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Infectious Diseases, 196 papers in Epidemiology and 81 papers in Surgery. Recurrent topics in Marc Lipman's work include Tuberculosis Research and Epidemiology (176 papers), Pneumocystis jirovecii pneumonia detection and treatment (100 papers) and Mycobacterium research and diagnosis (74 papers). Marc Lipman is often cited by papers focused on Tuberculosis Research and Epidemiology (176 papers), Pneumocystis jirovecii pneumonia detection and treatment (100 papers) and Mycobacterium research and diagnosis (74 papers). Marc Lipman collaborates with scholars based in United Kingdom, United States and South Africa. Marc Lipman's co-authors include Ibrahim Abubakar, Ronan Breen, Margaret Johnson, Timothy D. McHugh, Colette Smith, Punam Mangtani, Laura C. Rodrigues, Jonathan A C Sterne, Peter G. Smith and George Janossy and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Marc Lipman

278 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials

2013 656 citations Ibrahim Abubakar, Marc Lipman et al. profile →
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19

2020 575 citations Marc Lipman, John R. Hurst et al. Thorax profile →

Peers

Countries citing papers authored by Marc Lipman

Since Specialization

Citations

This map shows the geographic impact of Marc Lipman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Lipman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Lipman more than expected).

Fields of papers citing papers by Marc Lipman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Lipman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Lipman. The network helps show where Marc Lipman may publish in the future.

Co-authorship network of co-authors of Marc Lipman

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Lipman. A scholar is included among the top collaborators of Marc Lipman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Lipman. Marc Lipman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic Obstructive Pulmonary Disease in People with HIV: an Evidence-Based Review 2025 ·HIV/AIDS - Research and Palliative Care ·(unknown), (unknown), Tristan Barber, James Brown, Fiona Burns, John R. Hurst, Robert F. Miller, Marc Lipman	0
2	Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review 2023 ·SHILAP Revista de lepidopterología ·Rebecca F. Baggaley, Carolin Vegvari, Christian Akem Dimala, Marc Lipman, Robert F. Miller, James Brown, (unknown), Helena White, T. Déirdre Hollingsworth, Manish Pareek	1
3	Management and control of tuberculosis control in socially complex groups: a research programme including three RCTs 2020 ·SHILAP Revista de lepidopterología ·Alistair Story, Elizabeth Garber, Robert W Aldridge, Catherine M. Smith, (unknown), Gloria Ferenando, (unknown), (unknown), Fatima Wurie, Serena Luchenski, Ibrahim Abubakar, Timothy D. McHugh, Peter J White, John Watson, Marc Lipman, Richard S. Garfein, Andrew Hayward	5
4	Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea 2020 ·BMJ Open ·Jinsoo Min, Hyung Woo Kim, Helen R. Stagg, Marc Lipman, Molebogeng X. Rangaka, Jun‐Pyo Myong, Hyeon Woo Yim, Jeong Uk Lim, Yunhee Lee, Hyeon‐Kyoung Koo, Sung-Soon Lee, Jae Seuk Park, Kyung Sook Cho, Ju Sang Kim	9
5	IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial 2019 ·BMJ Open ·Helen R. Stagg, Ibrahim Abubakar, Colin Campbell, Andrew Copas, Marcia Darvell, Robert Horne, Karina Kielmann, Heinke Kunst, (unknown), (unknown), Alistair Story, Nicole Vidal, Fatima Wurie, Marc Lipman	6
6	The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world? 2019 ·International Journal of Infectious Diseases ·Isobella Honeyborne, Marc Lipman, Alimuddin Zumla, Timothy D. McHugh	20
7	Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study 2018 ·Health Technology Assessment ·Ibrahim Abubakar, Ajit Lalvani, (unknown), Alice Sitch, Charlotte Jackson, Olu Onyimadu, Marc Lipman, Jonathan J Deeks, Chris Griffiths, Graham Bothamley, Onn Min Kon, Andrew Hayward, Joanne Lord, Francis Drobniewski	21
8	Testing for TB in a contemporary UK HIV clinic - is it really worth it? 2016 ·UCL Discovery (University College London) ·(unknown), Janey Sewell, Colette Smith, (unknown), Sanjay Bhagani, (unknown), Ibrahim Abubakar, Sherry Johnson, Marc Lipman	3
9	Managing latent tuberculosis in UK renal transplant units: how does practice compare with published guidance? 2014 ·Clinical Medicine ·(unknown), (unknown), Susan Hopkins, Mark Harber, Marc Lipman	5
10	Using virtually observed treatment (VOT) for hard to manage tuberculosis: A pilot study 2013 ·European Respiratory Journal ·(unknown), Alistair Story, (unknown), Susan Yates, Gloria Ferenando, (unknown), Robert W Aldridge, Andrew Hayward, Elizabeth Garber, Marc Lipman, John Watson	1
11	Is testing for latent tuberculosis infection in an UK HIV clinic cost effective? 2012 ·UCL Discovery (University College London) ·(unknown), C. Smith, (unknown), Sanjay Bhagani, (unknown), Jun Ma, Marc Lipman	1
12	Effect of patient smoking status on CD4 count change after initiation of antiretroviral therapy 2012 ·UCL Discovery (University College London) ·Rebecca Lodwick, Sherry Johnson, Colette Smith, Marc Lipman, (unknown), Mervyn Tyrer, Andrew Phillips, Fiona Lampe	1
13	Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice 2011 ·Journal of Antimicrobial Chemotherapy ·Ann Sturdy, Anna L. Goodman, Ricardo J. José, Angela Loyse, (unknown), Onn Min Kon, Martin Dedicoat, Thomas S. Harrison, Laurence John, Marc Lipman, Graham Cooke	69
14	Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis 2010 ·UCL Discovery (University College London) ·(unknown), (unknown), (unknown), Timothy D. McHugh, Andrew Nunn, Marc Lipman, Stephen H. Gillespie	38
15	Does visualisation of the bronchial tree add value when investigating possible lung infection? 2006 ·UCL Discovery (University College London) ·(unknown), A Macdonald, (unknown), Marc Lipman, (unknown)	0
16	Messenger RNA as a marker of treatment response in pulmonary tuberculosis 2005 ·UCL Discovery (University College London) ·(unknown), (unknown), (unknown), Johirul Islam, Timothy D. McHugh, Marc Lipman, Stephen H. Gillespie	1
17	Is there an association between paradoxical reactions and mycobacterium tuberculosis strain type? 2004 ·UCL Discovery (University College London) ·(unknown), RJ Shorten, (unknown), Timothy D. McHugh, Marc Lipman	1
18	Clinical experience with lymphangioleiomyomatosis in the United Kingdom 1999 ·UCL Discovery (University College London) ·Marc Lipman, Romain Dubois	1
19	The clinical manifestations of HIV disease 1996 ·UCL Discovery (University College London) ·(unknown), Marc Lipman, Jun Ma	1
20	S1 Effect of chronic CPAP therapy on upper airway muscle reflex activity 1995 ·Thorax ·David L. Baldwin, (unknown), (unknown), Marc Lipman, (unknown), L W Poulter, (unknown), (unknown), D Pitson, R. J. O. Davies, John Stradling, M Bofill, (unknown), Pádraig Strappe, David P. Bray, Vincent C. Emery	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact